The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.
Medtronic has secured a CE mark approval in Europe for its surgical implant to close the heart’s left atrial appendage, aimed at reducing the long-term risk of stroke that’s higher among people with ...
Boston Scientific is working on a new version of its Watchman device, company leaders said at a Tuesday investor presentation. Angelo De Rosa, global president of Boston Scientific’s Watchman business ...
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...
Abstract: Percutaneous Left Atrial Appendage Closure (LAAC) is a minimally invasive procedure to prevent thromboembolic events in atrial fibrillation patients. The procedure's success relies on ...
New partner reinforces confidence in the company's progress and future potential. NASHUA, N.H., Aug. 12, 2025 /PRNewswire/ -- Conformal Medical, Inc., a medical device company developing ...
Jul. 26—dbeard @dominionpost.com MORGANTOWN — Vandalia Health Mon Medical Center is participating in a clinical trial that could forever change how patients with atrial fibrillation are treated. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback